Jeffrey Fryer
Keine laufenden Positionen mehr
Karriereverlauf von Jeffrey Fryer
Ehemalige bekannte Positionen von Jeffrey Fryer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RALLYBIO CORPORATION | Finanzdirektor/CFO | 01.01.2018 | 01.02.2023 |
Gründer | 01.01.2018 | 01.02.2023 | |
Treasurer | 01.01.2018 | 01.02.2023 | |
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.04.2008 | 01.04.2017 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Gründer | 01.01.2018 | - |
Ausbildung von Jeffrey Fryer
University of Hartford | Graduate Degree |
Bryant University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Founder | 2 |
Director of Finance/CFO | 1 |
Treasurer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Jeffrey Fryer
- Erfahrung